GPR39
Basic information
Region (hg38): 2:132416805-132646582
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPR39 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 25 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 27 | 3 | 4 |
Variants in GPR39
This is a list of pathogenic ClinVar variants found in the GPR39 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-132417070-G-C | not specified | Uncertain significance (Aug 26, 2022) | ||
2-132417230-A-G | not specified | Uncertain significance (Sep 14, 2023) | ||
2-132417275-C-T | not specified | Uncertain significance (Feb 17, 2022) | ||
2-132417417-C-A | not specified | Uncertain significance (Mar 25, 2024) | ||
2-132417445-A-G | not specified | Likely benign (Dec 28, 2022) | ||
2-132417478-G-A | not specified | Uncertain significance (Jul 26, 2022) | ||
2-132417483-G-A | Benign (Jun 10, 2018) | |||
2-132417634-C-A | not specified | Uncertain significance (Oct 25, 2023) | ||
2-132417641-A-G | not specified | Uncertain significance (May 02, 2024) | ||
2-132417663-G-T | not specified | Uncertain significance (Apr 19, 2024) | ||
2-132417664-T-G | not specified | Uncertain significance (Apr 19, 2024) | ||
2-132417677-A-G | Benign (Aug 20, 2018) | |||
2-132417763-A-G | not specified | Uncertain significance (Jan 23, 2024) | ||
2-132417811-C-G | not specified | Uncertain significance (Dec 05, 2022) | ||
2-132417853-A-C | not specified | Uncertain significance (Feb 10, 2022) | ||
2-132645123-C-A | Benign (Jul 10, 2017) | |||
2-132645124-G-T | not specified | Uncertain significance (Dec 21, 2023) | ||
2-132645145-A-C | not specified | Uncertain significance (Jun 07, 2024) | ||
2-132645199-T-C | not specified | Uncertain significance (Mar 02, 2023) | ||
2-132645284-C-T | not specified | Uncertain significance (Aug 22, 2023) | ||
2-132645310-G-C | not specified | Uncertain significance (Apr 19, 2024) | ||
2-132645337-C-A | not specified | Uncertain significance (Dec 02, 2022) | ||
2-132645338-T-G | not specified | Uncertain significance (Dec 02, 2022) | ||
2-132645341-A-C | not specified | Likely benign (Aug 21, 2023) | ||
2-132645341-A-G | not specified | Uncertain significance (Nov 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GPR39 | protein_coding | protein_coding | ENST00000329321 | 2 | 229986 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.81e-9 | 0.0462 | 125671 | 1 | 76 | 125748 | 0.000306 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.359 | 285 | 303 | 0.942 | 0.0000210 | 2954 |
Missense in Polyphen | 88 | 111.8 | 0.78713 | 1202 | ||
Synonymous | -0.131 | 143 | 141 | 1.01 | 0.0000110 | 942 |
Loss of Function | -0.575 | 12 | 10.0 | 1.20 | 4.33e-7 | 113 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000569 | 0.000569 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000142 | 0.000141 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.00144 | 0.00141 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Zn(2+) acts as an agonist. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Its effect is mediated mainly through G(q)-alpha and G(12)/G(13) proteins. Involved in regulation of body weight, gastrointestinal mobility, hormone secretion and cell death (By similarity). {ECO:0000250}.;
- Pathway
- GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;G alpha (s) signalling events;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (q) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.144
Intolerance Scores
- loftool
- 0.832
- rvis_EVS
- -0.09
- rvis_percentile_EVS
- 47.06
Haploinsufficiency Scores
- pHI
- 0.0978
- hipred
- N
- hipred_score
- 0.301
- ghis
- 0.403
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.202
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gpr39
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); digestive/alimentary phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway
- Cellular component
- plasma membrane;integral component of plasma membrane
- Molecular function
- G protein-coupled receptor activity;metal ion binding